Home › Free Stock Grades › NPCE
NeuroPace, Inc. (NPCE) Stock Grade
NPCE · Healthcare
C
Market Cap
$482.4M
P/E Ratio
—
Revenue Growth (YoY)
+25.1%
Net Margin
-21.5%
Return on Equity
—
Dividend Yield
None
About NeuroPace, Inc.'s fundamentals
NeuroPace is a medical device company with a market capitalization of $482.4 million that is currently unprofitable, reporting a net loss and a negative net margin of -21.5%. However, the company is experiencing strong revenue growth of 25.1% year-over-year, indicating expanding sales despite its current losses. The company does not pay a dividend, which is typical for early-stage medical device firms prioritizing reinvestment in growth and research and development.